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Weissella confusa is found in fermented foods and has been suggested as a probiotic, but
also causes sepsis and other serious infections in humans and animals. The incidence of
human infections is underestimated partly due to confusion with viridans streptococci
and partly due to difficulty making a definitive identification, even if the organism is
recognized to belong to another genus, owing to the inability of commercial organism
systems to identify it. We report our experiences identifying W. confusa isolated from two
immune-compromised patients, both of whom developed sepsis with this organism. Two
MicroScan gram positive combination panels, could not identify the organism because
they did not have W. confusa in their data bases, but did not provide a false identification.
Other laboratorians have reported failure to identify or false identifications of W. confusa
with other commercial systems. W. confusa is in the data base of the RapID™ Str
panel (Remel), which gave three incorrect, high probability results (≥95%). 16S rDNA
sequencing identified the isolates as W. confusa. Maldi-Tof, performed by two of our
reference laboratories, also correctly identified both isolates. Use of W. confusa as a
probiotic should be approached with caution because its true incidence as an opportunisitic
pathogen is unknown.
Keywords: Weissella confusa bacteremia, Weissella confusa identification, MALDI-TOF mass spectrometry, 16S
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INTRODUCTION
A search in the PubMed data base for “Weissella confusa,” per-
formed on 24 June, 2013, revealed 74 articles about this organism.
Forty of them highlighted the finding of W. confusa in fermented
food, not including the initial paper by Collins et al. (1993) who
constructed the genusWeissella to include some organisms found
in fermented food sources. Others discussed its potential as a
probiotic (for example: Aveni et al., 2001; Lee et al., 2012). Two
species have been associated with human bacteremia: W. con-
fusa (formerly Lactobacillus confusus) and W. cibaria. W. confusa
infection is rare whichmay be due, in part, to the inability of com-
mercial systems to identify the organism. However there were 10
papers highlighting its role as a cause of human sepsis and bac-
teremia (Green et al., 1990; Olano et al., 2001; Bjorkroth et al.,
2002; Flaherty et al., 2007; Salimnia et al., 2010; Shin et al., 2007;
Harlan et al., 2011; Kumar et al., 2011; Lee et al., 2011; Fairfax and
Salimnia, 2012). These are mostly individual case reports from
immune-compromised hosts. However, one paper from Taiwan
reports a series of 10 bacteremias over a 10-year period (Lee et al.,
2011). About half of these were mixed infections in which the role
of theW. confusa was undeterminable. Many of the patients died,
but whether the outcome could be attributed directly to the W.
confusa is also uncertain.
We discussed our two W. confusa isolates from septic patients
in two previous papers. The first highlights the isolation of the
organism from two immune-compromised patients (Salimnia
et al., 2010). The second (Fairfax and Salimnia, 2012) emphasizes
that the organism is probably under-reported because, by spot
testing, it resembles a viridans streptococcus (Ruoff, 2002) and
therefore may be reported as a skin contaminant and not worked
up (Hall and Lyman, 2006). However, this is not the only problem
with the identification ofW. confusa. Many commercial organism
identification systems fail to identify or mis-identify the organ-
ism (Salimnia et al., 2010; Lee et al., 2011; Fairfax and Salimnia,
2012). For an organism that is a candidate for inclusion in pro-
biotic regimens, this may be dangerous, as its true pathogenic
potential may not be appreciated. Our objectives with this paper
are to highlight our difficulties with the organism identification
in a clinical laboratory, to describe their possible resolutions,
and to emphasize the importance of delineating the role of this
opportunistic pathogen before deciding that it might be used as a
probiotic.
CASE REPORTS
PATIENT 1
A 34-year-old man received a successful allogeneic, unrelated
hematopoetic stem cell transplant for acute lymphocytic leukemia
and was discharged from the hospital. On day 23 post trans-
plant, he returned with fever, neutropenia, and graft failure. One
blood culture set was drawn. Empiric therapy with vancomycin
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(VAN) and aztreonam was begun. Both the aerobic and anaer-
obic bottles grew gram-positive cocci/coccobacilli in pairs and
chains. Although initially presumed to be a viridans streptococcus
because of its alpha-hemolytic colonies and spot testing results
(Ruoff, 2002) and a blood culture contaminant because it grew
in only one culture set (Hall and Lyman, 2006), the organism
was worked up at physician request. Two additional blood cul-
tures, drawn when the first set turned positive, grew the same
organism. The MicroScan (MS; Siemens Healthcare Diagnostics,
Sacramento, CA, USA) PC20 panel showed the organism to be
resistant (R) to VAN, metronidazole, and rifampin, and suscep-
tible (S) to other antibiotics on the panel appropriate for the
treatment of gram positive cocci. However, it gave no identifica-
tion. Etest (AB Biodisk, Solna SW) confirmed the VAN resistance
and revealed that the organism was S to daptomycin (DAP). DAP
therapy was begun and follow up cultures were negative.
PATIENT 2
A 58-year-old man with 2nd and 3rd degree burns received
extensive debridement, multiple skin grafts, a tracheotomy and
prolonged mechanical ventilation. Several bouts of polymicro-
bial bacteremia were treated with multiple courses of antibi-
otics including VAN. On hospital day 29, he again developed
bacteremia with both E. faecalis and a catalase-negative, gram-
positive coccobacillus that grew as pairs and chains both aero-
bically and anaerobically. Identification and susceptibility testing
were similar to those for Patient 1. His bacteremia resolved after
treatment with DAP.
MATERIALS AND METHODS
BLOOD CULTURES
All blood culture bottles were incubated in the Bactec 9240 blood
culture system (Becton Dickinson, Sparks, MD, USA) according
to the manufacturer’s instructions.
SPOT TESTS
The following spot tests were performed according to the manfac-
turers’ instructions: leucine amino peptidase (LAP Disk, Remel,
Lenexa, KS, USA), pyrrolidinyl aralamidase (PYR, Identicult®-
AE-PYR; PML Microbiologicals, Tualitin OR, USA).
COMMERCIAL IDENTIFICATION AND SUSCEPTIBILITY TESTING
The first organisms was tested on the MS PC20 panel. The sec-
ond organism was inoculated into the MS PC29 Panel to which
our laboratory had switched in the interim. After the MicroScan
failed to identify the organisms, we used the RapID™ Str (RapID,
Remel, Lenexa, Kansas, USA), according to the manufacturers’
instructions, to identify the organism. W. confusa is in the data
base of the panel.
E-tests for VAN and DAP (A B Biodisc, Solna, SW) were
performed according to themanufacturers instructions. The VAN
and DAP minimal inhibitory concentrations were ≥256μgm
ml−1 and 0.5μgm ml−1 respectively.
16S rDNA SEQUENCING
16S rDNA sequencing was performed using the MicroSeq Full
Gene 16S rDNA Bacterial Identification Kit (Applied Biosystems).
BLAST analysis was used to identify the organism (Nucleotide
collection (nr/nt) database, at the NCBI website; http://blast.ncbi.
nlm.nih.gov/Blast.cgi).
RESULTS
The MS gram-positive panels gave antibiotic susceptibility results
but failed to identify the organism. Several attempts at organism
identification using RapID gave three incorrect identifications
depending on the interpretation of ambiguous reactions, all at
probabilities greater than 95%: Streptococcus intermedius, Listeria
monocytogenes, Pediococcus pentosaceus (Table 1). On RapID, W.
confusa should have been positive for arginine (ARG) and esculin
(ESC) hydrolysis, and given negative reactions for all other
biochemicals (Table 1). The panel was run twice, on isolates
from different days, by different experienced technologists. The
first time the ARG, ESC, p-nitro-phenyl-α,D-glucoside (GLU), -
glucosaminide (NAG) and p-nitrophenyl phosphate (PO4) were
positive. This yielded an identification of Streptococcus inter-
medius with a probability of 95.8%, although the web site cau-
tioned that lysine-negative isolates were uncommon. The second
time, ARG and PO4 hydrolysis were negative and GLU and NAG
were ambiguous. If GLU and NAG were interpreted as positive,
the isolate should have been Listeria monocytogenes. If both were
negative, it would have coded as Pediococcus pentosaceus. These
organisms were eliminated by colony and/or gram stainmorphol-
ogy, and by the results from the MS panels. The organism was
subjected to rDNA sequencing.
The sequence obtained by 16S rDNA sequencing had 100%
identity to W. confusa strain Inje LM S-338 (DQ321751.1) with
no gaps and a maximum score of 2754.
The organism from the second patient was similar in colony
and gram stain morphology and in spot test results to the isolate
from patient 1. However it was not assumed to be a contaminant
as it grew in both bottles of two different blood cultures. It was
analyzed on the Microscan MS PC29 panel which also did not
identify the isolate. The biochemical and antibiotic susceptibility
results were similar to those of the first isolate, except for a positive
Voges-Proskauer (VP, acetoin) reaction. The W. confusa isolate
reported by Olano et al. (2001), and those in references cited by
them, gave negative VP reactions. It was also sent for 16S rDNA
analysis and the sequence was 100% identical to the first patient’s
isolate. It was then inoculated into the RapID panel, which again
failed to support an identification asW. confusa (Table 1).
DISCUSSION
Weissella confusa is appropriately named. Difficulty identifying it
by standard clinical laboratory techniques may contribute to an
underappreciation of its role as an opportunistic pathogen. This
is highlighted by our experience with two cases ofW. confusa caus-
ing serious infections in immune compromised patients. Initially
thought to be viridans streptococci, and skin contaminants
because they were catalase and PYR negative and LAP positive
(Ruoff, 2002), the isolates from our two immune-compromised
patients might have been dismissed as contaminants if the physi-
cian for the first had not requested identification and if the second
had not grown in multiple blood cultures sets (Hall and Lyman,
2006). Commercial organism identification and susceptibility
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Table 1 | Biochemical reactions of Weissella confusa isolates from Patients 1 and 2 compared with identification criteria from commercial
identification systems.
Testing modality Reaction Pt 1 Pt 2 RapID™ STR MS MS P. pentosaceus
Wc* Wc Wc** E. gal3 P. sp4 KonemanÔ
Blood agar Hemolysis α α α, γ α
Spot tests Catalase − − − − − −
LAP6 + + +
PYR7 − −
Gram stain8 +c/cbpr and ch +c/cbpr and ch +cpr and ch +cclus +cclus
Microscan PC20 and PC299 BE + + 95 10
NACL + + 99 1
PYR10 − − 75 1 −
NOV + + 10 25 +
ARG + + 50 5 +
BAC + + 99 95
CV − − 95 1
OPT + + 99 95
MS + + 99 90
NIT − − 1 1
PGR − − 5 1
IDX − − 10 1
VP − + 95 1
PHO − − 25 1
PGT + + 99 90
URE − − 1 1
MAN10 − − 99 5
LAC − − 99 5
TRE − − 99 90
MNS + + 99 99
SOR10 − − 1 5
ARA − − 90 90
RBS − − 5 95
INU10 − − 10 1
RAF10 − − 50 1
PRV − − 1 1 RapID™ Str
RapID™ Str ARG11 ±12 + 95 2
ESC + + 98 96
RAF − − 0 0
GAL − + 0 0
GLU +/±13 − 0 0
NAG +/± − 2 2
PO4 − ± 0 0
TYR − − 1 1
HPR − − 0 0
LYS − − 0 0
*Wc: Weissella confusa.
**W. confusa biochemical reactions according to the package insert with the RapID™ STR panel.
3E. gal: Enterococcus gallinarum biochemical reactions as shown in MicroScan literature.
4Pediococcus species biochemical reactions as shown in MicroScan literature.
ÔP. pentosaceus biochemical reactions from Winn et al. (2006).
6LAP, leucine aminopeptidase.
7PYR, pyrrolidinyl arylamidase.
8Abbreviations for the gram stain interpretation are: c, cocci; cb, coccobacilli; pr, pairs; ch, chains; clus, clusters.
9The reagent names on the MicroScan panels are as follows: BE, 40% bile esculin; NACL, 6.5% sodium chloride; PYR, L-pyrrolidonyl-β-naphthylamide; NOV, novobiocin,
ARG, arginine; BAC, bacitracin; CV, crystal violet; OPT, optochin; MS, Micrococcus screen, NIT, nitrate; PGR, PNP-β-D-glucuronide; IDX, indoxyl phosphatase; VP, Voges-
Proskauer; PGT, PNP-β-D-galactopyranoside, URE, urea; MAN, mannitol; LAC, lactose; TRE, trehalose; MNS, mannose; SOR, sorbitol; ARA, arabinose, RBS, ribose; INU,
Inulin; PRV, pyruvate. All the biochemical reagents from the Microscan PC20 and 29 panels are included here, but they have been reordered to place those that we
consider most important for Weissella confusa identification at the top of the column.
10These reagents appear both in the Microscan and RapID™ Str panels, were concordant and negative for both isolates, and were supposed to give a negative reaction
for W. confusa according to the RapID™ Str panel information. Accordingly they were deleted from RapID™ Str reagent list to avoid duplication.
11Reagent names from the RapID™ Str panel are as follows: ARG, L arginine; ESC, esculin; RAF, raffinose; GAL, p-nitrophenyl-α,D-galactoside; GLU, p-nitrophenyl-α,D-
glucoside; PO4, p-nitrophenyl phosphate; TYR, tyrosine β-naphthylamide; HPR, hydroxyproline β-naphthylamide; LYS, lysine β-naphthylamide. See also footnote 10.
12Different reactions from two different blood culture isolates from patient one, drawn 2 days apart.
13± Ambiguous reaction requiring subjective interpretation.
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testing systems play increasing roles in US microbiology, and it
is important that they provide accurate identification or indicate
that the organism cannot be identified by their system.
W. confusa is not in the MicroScan data base and their PC20
and PC29 panels did not provide an identification, but the bio-
chemical reactions pointed in the correct direction. W. confusa is
in the data base of the RapID panel, but it provided three incor-
rect, high-probability identifications on the isolates from the first
patient and failed to confirm the identity of the second (Table 1).
16S rDNA sequencing identifiedW. confusa.
Lee et al. (2011) reported that none of their ten W. con-
fusa isolates were identified, even to the species level, by the
Phoenix Automated Microbiology System (Becton Dickinson)
and the Vitek 2 system (BioMerieux. Marcy l’Etoile, France).
The former system identified five of the isolates as Leuconostoc
mesenteroides, and two as Streptococcus bovis II, and one each was
identified as Lactobacillus lactis and Staphylococcus hominis. One
remained unidentified. On the Vitek, four were identified as L.
pseudo-mesenteroides, two as Pediococcus pentosaceus, and one as
Steptococcus agalactiae/ equinus. Three were not identified. We
believe that it is more dangerous to provide a false characteri-
zation of the organism, than to say that the organism cannot be
identified. This is expecially true in cases when the actual antibi-
otic susceptibilities of the organism differ from those that would
be associated with the organism that was erroneously identified
(S. agalactiae).
Matrix-assisted laser desorption ionization time-of-flight
(Maldi-ToF) is increasingly being used as an organism identi-
fication system, particularly in large microbiology laboratories,
because it is fast, accurate, and generally regarded as economical,
despite its high initial cost. It is less costly and less labor-intensive
than 16S rDNA sequencing. We sent both isolates to two refer-
ence laboratories for identification and both were identified as
W. confusa by Maldi-ToF. Furthermore, Fusco et al. (2011) have
developed a PCR assay which is specific for W. confusa and could
be used to unambiguously identify it in foods and clinical spec-
imens. Thus it is hoped that future W. confusa isolates may be
rapidly and accurately identified.
VAN is generally regarded as an essential component in gram-
positive and empiric antibiotic regimens. This is clearly not the
case, however, and Leuconostoc, Lactobacillus, Pediococcus, some
Enterococcus sp. as well as W. confusa have been reported to be
intrinsically R to VAN (see Lee et al., 2012). Our two isolates were
also R to metronidazole. They were susceptible to all other antibi-
otics that are generally regarded as suitable for gram-positive
cocci. However, Lee et al. (2012) reported that their 10 iso-
lates were all resistant to trimethoprim-sulfamethoxazole (MIC≥
128μgm ml−1).
In conclusion, although W. confusa is a known opportunis-
tic pathogen, it is difficult to identify in the clinical laboratory.
It appears to be relatively common in fermented foods, and has
been proposed as a probiotic although it is intrinsically resistant
to vancomycin. It may be selected for in those who have received
vancomycin therapy, as did our second patient presented above.
Then it may be identified as a viridans Streptococcus because of
its colony morphology, gram-stain morphology, and spot test-
ing results, and not fully worked up or treated, as was almost
the case with our first patient. Furthermore, even if it is recog-
nized as the etiologic agent of disease, it is either not identified or
mis-identified by major commercial organism identification sys-
tems that are used in clinical microbiology laboratories. Thus the
incidence of disease caused by W. confusa is likely to be seriously
underappreciated, and its inclusion in probiotic regimens should
proceed with caution. Maldi-ToF is becoming more common in
clinical laboratories throughout the world, and it is hoped that, if
W. confusa is in the data base, the full spectrum of disease caused
by this organism will be better recognized.
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AUTHOR NOTE
Some of this information was presented at the CombinedMeeting
of the International Congress on Antimicrobial Agents and
Chemotherapy and the Infectious Diseases Society of America,
Chicago, IL, USA in October 2008 (abstract number D-4004), It
was also published as a case report (Salimnia et al., 2010) and
as one of the cases in a review article about unusual etiologic
agents of sepsis that can appear to be blood culture contaminants
(Fairfax and Salimnia, 2012).
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